	US 12,077,749 B2
	Bifidobacterium longum subsp. infantis with fimbriae and applications thereof
Lili Zhang, Harbin (CN); Hui Sun, Harbin (CN); Zihe Xu, Harbin (CN); Ze Tan, Harbin (CN); Lihong Xiao, Harbin (CN); and Mingxue He, Harbin (CN)
Assigned to Northeast Agricultural University, Harbin (CN)
Filed by Northeast Agricultural University, Harbin (CN)
Filed on Aug. 31, 2023, as Appl. No. 18/241,009.
Claims priority of application No. 202211286087.4 (CN), filed on Oct. 20, 2022.
Prior Publication US 2024/0182847 A1, Jun. 6, 2024
Int. Cl. C12N 1/20 (2006.01); A61K 35/00 (2006.01); A61K 35/745 (2015.01); C12R 1/01 (2006.01)

CPC C12N 1/205 (2021.05) [A61K 35/745 (2013.01); A61K 2035/115 (2013.01); C12R 2001/01 (2021.05)]

1 Claim

1. A method for inhibiting Escherichia coli, comprising:

administering to a subject a product comprising a strain of Bifidobacterium longum subsp. infantis Y46 with fimbriae (BI_Y46) in an effective amount,

wherein the BI_Y46 is deposited in China Typical Culture Preservation Center, Wuhan, China, with an accession number of CCTCC NO: M 20221253, dated Aug. 9, 2022.